Alex Goldberg

Delcath Systems, Inc. (NASDAQ:DCTH) and Xilinx Inc. (NASDAQ:XLNX) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/17/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Delcath Systems, Inc. (NASDAQ:DCTH) and Xilinx Inc. (NASDAQ:XLNX).

Delcath Systems, Inc. (NASDAQ:DCTH) operates as a specialty pharmaceutical and medical device company focusing on the field of oncology is currently down (-9.23%) on 10,267,069 shares traded. Delcath Systems, Inc. (NASDAQ:DCTH) is currently down (-84.93%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Delcath Systems, Inc. (NASDAQ:DCTH)

Xilinx Inc. (NASDAQ:XLNX) a company that designs and develops programmable devices and associated technologies worldwide is currently up (+0.42%) on 1,796,956 shares traded after Xilinx Zynq-7000 All Programmable SoCs Enabled Wuhan Maxsine's EP3E Servo Drive. Xilinx Inc. (NASDAQ:XLNX) is currently up (+36.65%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Xilinx Inc. (NASDAQ:XLNX)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com